Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors. Its structure supports the construction of bioactive molecules with potential applications in cancer therapy and inflammatory diseases. The presence of the fluoro and morpholino groups enhances binding selectivity and metabolic stability in final drug candidates. Commonly employed in peptide coupling reactions and solid-phase synthesis due to the protecting group compatibility of the benzyloxycarbonyl moiety.